Spire Wealth Management’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Spire Wealth Management’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-33	Closed	-$1K	–	2651
2022 Q2	$1K	Sell	33 -1	-3%	-$25	﹤0.01%	2606
2022 Q1	$1K	Hold	34	–	–	﹤0.01%	2493
2021 Q4	$1K	Hold	34	–	–	﹤0.01%	2906
2021 Q3	$3K	Hold	34	–	–	﹤0.01%	2426
2021 Q2	$3K	Sell	34 -125	-79%	-$11.9K	﹤0.01%	2444
2021 Q1	$19K	Buy	+159	New	+$17.6K	﹤0.01%	2176

Other funds holding CSCI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Spire Wealth Management's CSCI Position: Q3 2022 in Review

Spire Wealth Management sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2022, closing a stake of 33 shares — an estimated $1K sold.

Spire Wealth Management first reported a position in CSCI in Q1 2021 and held it in 6 quarters. The position peaked at $19K in Q1 2021. 12 funds tracked by Wall St. Rank hold CSCI as of Q3 2022.

Spire Wealth Management reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Spire Wealth Management sold 33 COSCIENS Biopharma Inc. Common Stock shares in Q3 2022, an estimated $1K.
Spire Wealth Management first reported a position in COSCIENS Biopharma Inc. Common Stock in Q1 2021 and held it in 6 quarters.
Spire Wealth Management's COSCIENS Biopharma Inc. Common Stock position peaked at $19K in Q1 2021.
12 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2022.

Based on Spire Wealth Management's 13F filing for Q3 2022, filed 7 Nov 2022.